Wikidata

(Q54253940)

English

Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group

scientific article

In more languages

Statements

title
Clinical trial of Δ1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer:A report of the cooperative breast cancer group (English)
reason for preferred rank
most precise value
1 reference
stated in
Crossref
DOI
10.1002/1097-0142(196901)23:1<109::AID-CNCR2820230112>3.0.CO;2-1
reference URL
https://api.crossref.org/works/10.1002/1097-0142(196901)23:1%3C109::AID-CNCR2820230112%3E3.0.CO;2-1
retrieved
14 March 2023
Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
4884063
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4884063
retrieved
14 March 2023

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q54253940&oldid=1852111092"